Captrust Financial Advisors Boosts Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Captrust Financial Advisors raised its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 66.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,784 shares of the company’s stock after purchasing an additional 5,108 shares during the quarter. Captrust Financial Advisors’ holdings in Acadia Healthcare were worth $507,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of ACHC. Lindbrook Capital LLC increased its stake in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. boosted its holdings in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after acquiring an additional 301 shares during the period. Signaturefd LLC raised its holdings in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after purchasing an additional 933 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $26.15 on Monday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s 50-day moving average price is $26.19 and its 200 day moving average price is $35.49. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The stock has a market cap of $2.41 billion, a price-to-earnings ratio of 8.57, a PEG ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period in the prior year, the business earned $0.84 earnings per share. The company’s quarterly revenue was up .3% on a year-over-year basis. As a group, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ACHC. Mizuho cut their target price on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a research note on Wednesday, May 14th. Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. KeyCorp cut their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Finally, Guggenheim started coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.